Baird Starts Catalyst Pharmaceutical Partners (CPRX) at Outperform
Tweet Send to a Friend
(Updated - February 4, 2025 5:07 AM EST)
Baird analyst Joel Beatty initiates coverage on Catalyst Pharmaceutical Partners (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Joel Beatty initiates coverage on Catalyst Pharmaceutical Partners (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
